A Phase III Prospective Randomized Trial Of Dose-Escalated Radiotherapy With Or Without Short-Term Androgen Deprivation Therapy For Patients With Intermediate-Risk Prostate Cancer
Cancer - Prostate,
Seth Kaufman, MD
D’Amour Center for Cancer Care
3350 Main Street, Springfield MA 01199
The purpose of this study is to compare the effects of dose-escalated radiation therapy with or without hormone therapy on your prostate cancer.
Intermediate risk prostate cancer; no prior radical surgery for prostate cancer or prior hormonal therapy
Rae Lynn Defeo